drugset / Trial / NCT06324435
Apremilast for Alcohol Use Disorder Treatment in Women and Men
Phase 1
Active not recruiting
10 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabOffice of Research on Women's Health (ORWH) · collab
NaSingle-groupOpen-labelOther
Summary
For this protocol, the investigators plan to collect pilot data to evaluate apremilast (60mg/day) in adults with Alcohol Use Disorders (AUD).
Timeline
- Start
- 2024-05-08
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apremilast | Small molecule | 60 mg | Oral |